Treatment-Related Serious Adverse Events of Immune Checkpoint Inhibitors in Clinical Trials: A Systematic Review

BACKGROUND: Immune Checkpoint Inhibitors (ICI) have been progressively used in cancer treatment and produced unique toxicity profiles. This systematic review aims to comprehend the patterns and occurrence of treatment-related adverse events (trAEs) based on ICI. METHODS: PICOS/PRISMA methods were us...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Tao, Cao, Yanyan, Kan, Xuefeng, Chen, Lei, Ren, Yanqiao, Sun, Tao, Yan, Liangliang, Xiong, Bin, Liang, Bin, Zheng, Chuansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144509/
https://www.ncbi.nlm.nih.gov/pubmed/34046338
http://dx.doi.org/10.3389/fonc.2021.621639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144509/
https://www.ncbi.nlm.nih.gov/pubmed/34046338
http://dx.doi.org/10.3389/fonc.2021.621639

Ejemplares similares